Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?

Table 1

Patients’ characteristics.

	No. (%)
Total number	159 pts
Age
<50	40 (25.2)
≥50	119 (74.8)
Tumor samples
Primary	159 (100)
Metastasis	24 (15.1)
Both	24 (15.1)
T at diagnosis
1	73 (50.0)
2	56 (38.4)
3	5 (3.4)
4	12 (8.2)
Unknown	13
N at diagnosis
0	59 (41.8)
1	52 (36.9)
2	14 (9.9)
3	16 (11.4)
Unknown	18
M at diagnosis
0	122 (76.7)
1	37 (23.3)
Grade
1	6 (4.8)
2	48 (38.1)
3	72 (57.1)
Unknown	33
Adjuvant systemic therapy
No adjuvant therapy	12 (7.5)
Chemotherapy	84 (52.8)
Hormone therapy	84 (52.8)
Both	58 (36.5)
Unknown	37 (23.3)